Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Smith EA, Belote RL, Cruz NM, Moustafa TE, Becker CA, Jiang A, Alizada S, Prokofyeva A, Chan TY, Seasor TA, Balatico M, Cortes-Sanchez E, Lum DH, Hyngstrom JR, Zeng H, Deacon DC, Grossmann AH, White RM, Zangle TA, Judson-Torres RL. Smith EA, et al. Among authors: white rm. J Exp Clin Cancer Res. 2024 Dec 3;43(1):317. doi: 10.1186/s13046-024-03234-1. J Exp Clin Cancer Res. 2024. PMID: 39627834 Free PMC article.
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State.
Johns E, Ma Y, Louphrasitthiphol P, Peralta C, Hunter MV, Raymond JH, Molina H, Goding CR, White RM. Johns E, et al. Among authors: white rm. Pigment Cell Melanoma Res. 2025 Jan;38(1):e13208. doi: 10.1111/pcmr.13208. Epub 2024 Oct 31. Pigment Cell Melanoma Res. 2025. PMID: 39479752
Ancestry and somatic profile predict acral melanoma origin and prognosis.
Basurto-Lozada P, Vázquez-Cruz ME, Molina-Aguilar C, Jiang A, Deacon DC, Cerrato-Izaguirre D, Simonin-Wilmer I, Arriaga-González FG, Contreras-Ramírez KL, Dawson ET, Wong-Ramirez JRC, Ramos-Galguera JI, Álvarez-Cano A, García-Ortega DY, García-Salinas OI, Hidalgo-Miranda A, Cisneros-Villanueva M, Martínez-Said H, Arends MJ, Ferreira I, Tullett M, Olvera-León R, van der Weyden L, Del Castillo Velasco Herrera M, Roldán-Marín R, Vidaurri de la Cruz H, Tavares-de-la-Paz LA, Hinojosa-Ugarte D, Belote RL, Bishop DT, Díaz-Gay M, Alexandrov LB, Sánchez-Pérez Y, In GK, White RM, Possik PA, Judson-Torres RL, Adams DJ, Robles-Espinoza CD. Basurto-Lozada P, et al. Among authors: white rm. medRxiv [Preprint]. 2024 Sep 23:2024.09.21.24313911. doi: 10.1101/2024.09.21.24313911. medRxiv. 2024. PMID: 39399030 Free PMC article. Preprint.
How and why eLife selects papers for peer review.
eLife Editorial Leadership; eLife Senior Editors; eLife Early Career Advisory Group. eLife Editorial Leadership, et al. Elife. 2024 Jul 23;13:e100571. doi: 10.7554/eLife.100571. Elife. 2024. PMID: 39041434 Free PMC article.
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Smith EA, Belote RL, Cruz NM, Moustafa TE, Becker CA, Jiang A, Alizada S, Chan TY, Seasor TA, Balatico M, Cortes-Sanchez E, Lum DH, Hyngstrom JR, Zeng H, Deacon DC, Grossmann AH, White RM, Zangle TA, Judson-Torres RL. Smith EA, et al. Among authors: white rm. bioRxiv [Preprint]. 2024 Jun 17:2024.06.15.599116. doi: 10.1101/2024.06.15.599116. bioRxiv. 2024. Update in: J Exp Clin Cancer Res. 2024 Dec 3;43(1):317. doi: 10.1186/s13046-024-03234-1 PMID: 38948879 Free PMC article. Updated. Preprint.
371 results